Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660 

Pharmaceutical

Life Sciences

Biotechnology

Exothera

Exothera's headquarters in Jumet, Belgium

Céline Delecourt

Lander Monné

Vladimir Ivošev

Fabien Baldacci-Cresp

Koen Coorevits

Thomas le Gall

Dmitry Sorokin

Benjamin Depierreux

Solène Arnoult

Nicolas Delrée

Description

People (7)